全球脐带血库市场规模、份额、趋势和成长分析报告（2026-2034年）

预计脐带血库市场将从 2025 年的 340 亿美元成长到 2034 年的 670.7 亿美元，2026 年至 2034 年的复合年增长率为 7.84%。

随着细胞疗法和再生医学的应用范围从血液学领域扩展到更广泛的免疫疗法和组织修復领域，脐带血库正步入发展阶段。脐带血富含造血干细胞和前驱细胞，可用于移植医学，并作为基因工程免疫细胞和再​​生医学构建体等细胞治疗方法的新型储存库而备受关注。随着从自体免疫疾病到新生儿脑损伤等新适应症在临床试验中得到证实，对高品质冷冻保存的脐带血及其相关生物银行服务的需求将持续增长。策略差异化将取决于脐带血的品质、处理方法以及提供相关临床数据的能力，从而增强其临床应用价值。

工艺创新和标准化是获得竞争优势的关键。封闭式自动化收穫和处理平台可降低污染风险并提高活细胞产量。标准化的活力测量、疗效指标和稳健的控制链系统可增强临床可靠性。先进的冷冻保存通讯协定、优化的冷冻保护剂化学成分和可控速率冷冻技术可提高长期细胞回收率，使储存的细胞更可靠，可用于后续治疗应用。区块链和安全数位记录正在试点应用，以保持与来源、知情同意以及母婴健康数据的关联，从而在满足数据隐私监管要求的同时，促进相关调查。

市场成长将受法规结构和临床证据的影响。随着监管机构明确脐带血衍生细胞治疗产品的核准途径，遵循GMP规范并提供符合监管要求文件的脐带血库将赢得医疗机构的青睐。脐带血库、生技公司和医院之间的合作将建构转化医学流程，使储存的脐带血成为自体和异体移植疗法的来源。在新兴市场的地域扩张，以及本土认证体系和宣传活动的支持下，将提升脐带血的收集量。同时，提供公共、私人和指定捐赠选项的混合服务模式将为家庭和医疗系统创造灵活的价值提案。总而言之，脐带血库产业有望成为下一代细胞疗法和个人化再生医学策略的基础。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球脐带血库市场：依服务类型划分

• 市场分析、洞察与预测
• 收集/运输
• 过程
• 分析
• 保持

第五章：全球脐带血库市场：依血库划分

• 市场分析、洞察与预测
• 私人的
• 公共
• 杂交种

第六章 全球脐带血库市场：依组成部分划分

• 市场分析、洞察与预测
• 脐带血
• 脐带组织

第七章 全球脐带血库市场：依应用划分

• 市场分析、洞察与预测
• 癌症
• 遗传性疾病
• 血液疾病
• 免疫力缺乏
• 代谢性疾病
• 其他用途

第八章：全球脐带血库市场：依最终用途划分

• 市场分析、洞察与预测
• 医院
• 製药和生物技术公司
• 学术研究机构

第九章 全球脐带血库市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第十章 竞争格局

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十一章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Global Cord Blood Corporation
  • CBR Systems Inc
  • Cryo-Cell International
  • Cordlife Group Limited
  • AlphaCord LLC
  • CSG-BIO
  • California Cryobank Stem Cell Services LLC
  • Cord Blood Foundation（Smart Cells International）
  • Singapore Cord Blood Bank
  • FamiCord

The Cord Blood Banking Market size is expected to reach USD 67.07 Billion in 2034 from USD 34.00 Billion (2025) growing at a CAGR of 7.84% during 2026-2034.

Cord blood banking is entering a growth phase as cellular therapies and regenerative medicine expand beyond hematologic applications into broader immunotherapies and tissue repair. Cord blood is a rich source of hematopoietic stem and progenitor cells used in transplant medicine and an emerging reservoir for cell-based interventions such as engineered immune cells and regenerative constructs. As clinical trials validate novel indications-ranging from autoimmune disorders to neonatal brain injury-demand for high-quality, cryopreserved cord blood units and companion biobanking services will rise. Strategic differentiation will hinge on unit quality, processing methods, and the ability to provide linked clinical data that enhances translational utility.

Process innovation and standardization are key competitive levers. Closed automated collection and processing platforms reduce contamination risk and ensure higher viable cell yields; standardized viability assays, potency metrics, and robust chain-of-custody systems bolster clinical confidence. Advanced cryopreservation protocols, optimized cryoprotectant chemistries, and controlled-rate freezing technologies improve long-term cell recovery, making banked units more reliable for later therapeutic use. Blockchain and secure digital records are being piloted to maintain provenance, consent, and linkage to maternal and neonatal health data-facilitating research while meeting regulatory expectations around data privacy.

Market growth will be shaped by regulatory frameworks and clinical evidence. As regulatory agencies clarify pathways for cell therapy products derived from cord blood, banks that adhere to GMP-grade processing and provide regulatory-ready documentation will capture institutional demand. Collaboration between cord blood banks, biotech companies, and hospitals will unlock translational pipelines where stored units become sources for autologous and allogeneic therapies. Geographic expansion into emerging markets-supported by localized accreditation and education campaigns-will broaden collection volumes. In parallel, hybrid service models offering public, private, and directed donation options will create flexible value propositions for families and health systems. Collectively, the cord blood banking sector is positioned to underpin a new generation of cellular therapeutics and personalized regenerative strategies.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Service

• Collection & Transportation
• Processing
• Analysis
• Storage

By Bank

• Private
• Public
• Hybrid

By Component

• Cord Blood
• Cord Tissue

By Application

• Cancer
• Genetic Disorders
• Blood Disorders
• Immune Deficiencies
• Metabolic Disorders
• Other Applications

By End-use

• Hospitals
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes

COMPANIES PROFILED

• Global Cord Blood Corporation, CBR Systems Inc, CryoCell International, Cordlife Group Limited, AlphaCord LLC, CSGBIO, California Cryobank Stem Cell Services LLC, Cord Blood Foundation Smart Cells International, Singapore Cord Blood Bank, FamiCord
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CORD BLOOD BANKING MARKET: BY SERVICE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Service
• 4.2. Collection & Transportation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Processing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Storage Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CORD BLOOD BANKING MARKET: BY BANK 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Bank
• 5.2. Private Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Public Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Hybrid Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CORD BLOOD BANKING MARKET: BY COMPONENT 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Component
• 6.2. Cord Blood Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Cord Tissue Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CORD BLOOD BANKING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Application
• 7.2. Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Genetic Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Blood Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Immune Deficiencies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Metabolic Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.7. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL CORD BLOOD BANKING MARKET: BY END-USE 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End-use
• 8.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL CORD BLOOD BANKING MARKET: BY REGION 2022-2034(USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Service
  • 9.2.2 By Bank
  • 9.2.3 By Component
  • 9.2.4 By Application
  • 9.2.5 By End-use
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Service
  • 9.3.2 By Bank
  • 9.3.3 By Component
  • 9.3.4 By Application
  • 9.3.5 By End-use
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Service
  • 9.4.2 By Bank
  • 9.4.3 By Component
  • 9.4.4 By Application
  • 9.4.5 By End-use
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Service
  • 9.5.2 By Bank
  • 9.5.3 By Component
  • 9.5.4 By Application
  • 9.5.5 By End-use
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 South East Asia
  • 9.5.11 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Service
  • 9.6.2 By Bank
  • 9.6.3 By Component
  • 9.6.4 By Application
  • 9.6.5 By End-use
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL CORD BLOOD BANKING INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Global Cord Blood Corporation
  • 11.2.2 CBR Systems Inc
  • 11.2.3 Cryo-Cell International
  • 11.2.4 Cordlife Group Limited
  • 11.2.5 AlphaCord LLC
  • 11.2.6 CSG-BIO
  • 11.2.7 California Cryobank Stem Cell Services LLC
  • 11.2.8 Cord Blood Foundation (Smart Cells International)
  • 11.2.9 Singapore Cord Blood Bank
  • 11.2.10 FamiCord